leon-nanodrugs (LEON) has closed a financing round designed to help meet rising demand for scalable nanoparticle manufacturing technologies.

LEON said its investors, both new and existing, “significantly” oversubscribed the funding, underscoring those investors’ conviction in the company’s proprietary technology.

LEON Systems and Platform

The company said investors also expressed enthusiasm for the technology’s commercial readiness. Accordingly, the funding will support market launch of LEON’s NANO systems. This platform addresses what LEON calls a “critical bottleneck” in the manufacturing of advanced therapeutics.

A key to the platform’s viability is LEON’s proprietary FR-JET mixing technology. This has been designed to overcome limitations in conventional approaches to nanoparticle manufacturing. LEON predicts it may have applications in RNA-based medicines, cancer vaccines, cell and gene therapies, and personalized treatments.

Frank Mühlenbeck, PhD, LEON Supervisory Board Chairman and LBBW Venture Capital Managing Partner, said LEON has reached an inflection point.

“We believe LEON is well positioned to emerge as a leader in scalable nanoparticle manufacturing,” Mühlenbeck said. He cited the company’s “market-ready systems, a differentiated technology base, and growing customer demand.”

Benefits for Nanoparticle Manufacturing

The specialized therapies that will benefit from the NANO systems need small-batch, rapid-turnaround, and good manufacturing practice (GMP)-scale settings. LEON says the platform can meet these demands, enabling robust scale-up without process redesign.

In turn, the company said, this provides a seamless transition from the early development stages through to commercial manufacturing. The platform intends to reduce operational risk, ensure consistent quality, and accelerate time-to-market.

Christian Nafe, LEON Chief Financial Officer, said the company is pointing toward “the next generation of therapeutics.”

“We are grateful for the strong confidence our investors continue to place in LEON,” Nafe said. Additionally, the financing provides “momentum to scale our commercial footprint, support our partners globally, and continue advancing a manufacturing platform.”